Hydroxyurea Produces Long-Term Clinical Benefits in Pediatrics With Sickle Cell Anemia

Source: Pharmacy Times articles

New research confirms hydroxyurea’s long-term effectiveness in reducing hospital visits for children with sickle cell anemia, supporting its use as standard treatment.
Read More